Monday, June 19, 2017
– Yesterday the innovative pharmaceutical industry and the Government of Alberta solidified a collaboration to ignite the life sciences sector in Alberta. This strategic partnership will identify ways to attract investment, expand research, improve patien
Thursday, May 18, 2017
Quest Pharmatech's subsiduary Madenco Biosciences offer new line of "cosmeceuticals" to target needs of dermatologists and medi-spas.
Oncolytic's proprietary immuno-oncology viral agent, REOLYSIN®, gets US FDA fast track approval.
OncoQuest Announces Enrollment of First Patient in Phase 1/2 Clinical Study Using Combination of Oregovomab with Checkpoint Inhibitor Nivolumab in Recurrent Ovarian Cancer
Major Edmonton biotech firm wins top Innovation Award for 2017 from Country’s top Chinese Business Association.
Legislation creating two credits: CITC & AITC will support at least 9,000 jobs and add $1.2 billion to Alberta’s GDP.
The Canada-Alberta Job Grant (CAJG) is a funding program where employers and government share the cost of training new and existing employees to increase their knowledge and skills to meet the needs of Alberta’s changing economy.